- Investing Ideas
- Canadian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Canadian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
19
Companies which are more than 50% undervalued based on analyst price target.
19 companies
Green Thumb Industries
Market Cap: CA$2.2b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$9.90
7D
-1.5%
1Y
28.4%
Verano Holdings
Market Cap: CA$586.7m
Engages in the cannabis business in the United States.
VRNO
CA$8.30
7D
-1.0%
1Y
124.3%
Eupraxia Pharmaceuticals
Market Cap: CA$567.0m
A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.
EPRX
CA$9.27
7D
-2.0%
1Y
28.7%
Canopy Growth
Market Cap: CA$553.0m
Engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally.
WEED
CA$1.34
7D
-2.2%
1Y
-10.1%
Cresco Labs
Market Cap: CA$463.2m
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.
CL
CA$1.05
7D
-2.8%
1Y
34.6%
Spectral Medical
Market Cap: CA$402.0m
Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.
EDT
CA$1.42
7D
5.2%
1Y
73.2%
TerrAscend
Market Cap: CA$283.5m
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.
TSND
CA$0.76
7D
-6.2%
1Y
58.3%
High Tide
Market Cap: CA$262.7m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.15
7D
1.0%
1Y
-6.8%
Aurora Cannabis
Market Cap: CA$225.5m
Engages in the production, distribution, and sale of cannabis products in Canada and internationally.
ACB
CA$3.70
7D
-4.1%
1Y
-40.5%
Cardiol Therapeutics
Market Cap: CA$200.6m
A clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
CRDL
CA$1.69
7D
17.4%
1Y
5.0%
Organigram Global
Market Cap: CA$173.2m
Engages in the production and sale of cannabis and cannabis-derived products in Canada.
OGI
CA$1.25
7D
-8.8%
1Y
-37.8%
HLS Therapeutics
Market Cap: CA$130.1m
A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally.
HLS
CA$4.11
7D
-4.6%
1Y
-16.1%
Decibel Cannabis
Market Cap: CA$66.4m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.11
7D
0%
1Y
10.0%
Vext Science
Market Cap: CA$61.9m
Through its subsidiaries, engages in integrated cannabis operations in the United States.
VEXT
CA$0.26
7D
10.9%
1Y
50.0%
Sernova Biotherapeutics
Market Cap: CA$41.5m
Operates as a clinical-stage biotechnology company in Canada.
SVA
CA$0.12
7D
-8.0%
1Y
-32.4%
Optimi Health
Market Cap: CA$39.3m
Operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada.
OPTI
CA$7.00
7D
7.9%
1Y
45.8%
Medicenna Therapeutics
Market Cap: CA$32.3m
A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.
MDNA
CA$0.35
7D
-5.4%
1Y
-58.3%
Rubicon Organics
Market Cap: CA$30.4m
Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.
ROMJ
CA$0.45
7D
0%
1Y
2.3%
Delivra Health Brands
Market Cap: CA$3.1m
Through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide.
DHB
CA$0.09
7D
-14.3%
1Y
-60.9%